OR WAIT null SECS
© 2022 MJH Life Sciences and Contemporary Pediatrics. All rights reserved.
© 2022 MJH Life Sciences™ and Contemporary Pediatrics. All rights reserved.
April 15, 2022
Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children
November 11, 2021
What we can look forward to in preventing infectious diseases.
November 02, 2021
Rochelle Walensky, MD endorsed the recommendation from the members of the CDC's Advisory Committee on Immunization Practices to administer Pfizer/BioNTech's COVID-19 vaccine for children aged 5-11 years.
October 29, 2021
The US Food and Drug Administration (FDA) has amended the emergency use authorization of the Pfizer/BioNTech vaccine to include children aged 5 to 11 years.
October 26, 2021
The US Food and Drug Administration (FDA) committee voted on whether the emergency use authorization should be extended to children aged 5 to 11 years.
The US Food and Drug Administration (FDA) is meeting to discuss amending the emergency use authorization of the Pfizer/BioNTech vaccine for children aged 5 to 11 years.
October 18, 2021
Seqirus’s FLUCELVAX® cell-based quadrivalent influenza vaccine has been approved to expand the age indication to children as young as 6 months of age by the US Food and Drug Administration.
September 20, 2021
Initial results from the trial indicate it was well-tolerated and promoted a good immune response.
September 14, 2021
Anthony S. Fauci, MD, Director of the National Institute of Allergy and Infectious Disease, reveals when he believes a COVID-19 vaccine for children aged less than 12 years will be available.
September 07, 2021
The American Academy of Pediatrics (AAP) has issued its recommendations for the upcoming influenza season, including guidance on administering the vaccine to patients with COVID-19.